MPPE1 and glioblastoma: This could reconcile the requirement for cDC1 observed by Bowman-Kirigin et al. with the necessity for CD4+ T cells demonstrated by Simonds et al. However, it is important to emphasize that these two studies utilized different cell lines to model GBM in mice, which may differ enough to stimulate two different immune responses upon treatment with ICB.